1. Home
  2. KTTA
  3. KTTA News

Latest Pasithea Therapeutics Corp. (KTTA) News on July 26, 2024

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial

GlobeNewswire

a month ago

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Twin Vee PowerCats Co Earnings Call

Share on Social Networks: